216 related articles for article (PubMed ID: 16155060)
1. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.
Malcolm RK; Woolfson AD; Toner CF; Morrow RJ; McCullagh SD
J Antimicrob Chemother; 2005 Nov; 56(5):954-6. PubMed ID: 16155060
[TBL] [Abstract][Full Text] [Related]
2. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
[TBL] [Abstract][Full Text] [Related]
3. Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy.
Bell SE; Dennis AC; Fido LA; Malcolm RK; Sirimuthu NM; Toner CF; Woolfson AD
J Pharm Pharmacol; 2007 Feb; 59(2):203-7. PubMed ID: 17270074
[TBL] [Abstract][Full Text] [Related]
4. Sustained release of microbicides by newly engineered vaginal rings.
Saxena BB; Han YA; Fu D; Rathnam P; Singh M; Laurence J; Lerner S
AIDS; 2009 May; 23(8):917-22. PubMed ID: 19381077
[TBL] [Abstract][Full Text] [Related]
5. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action.
Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK
Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.
Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK
J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093
[TBL] [Abstract][Full Text] [Related]
7. Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES.
McBride JW; Malcolm RK; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Devlin B; Boyd P
Int J Pharm; 2019 Jun; 564():207-213. PubMed ID: 30999049
[TBL] [Abstract][Full Text] [Related]
8. Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel.
Boyd P; Fetherston SM; McCoy CF; Major I; Murphy DJ; Kumar S; Holt J; Brimer A; Blanda W; Devlin B; Malcolm RK
Int J Pharm; 2016 Sep; 511(1):619-629. PubMed ID: 27473275
[TBL] [Abstract][Full Text] [Related]
9. Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring.
McCoy CF; Murphy DJ; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK
J Pharm Sci; 2017 Aug; 106(8):2015-2025. PubMed ID: 28456732
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates.
Promadej-Lanier N; Smith JM; Srinivasan P; McCoy CF; Butera S; Woolfson AD; Malcolm RK; Otten RA
J Med Primatol; 2009 Aug; 38(4):263-71. PubMed ID: 19476564
[TBL] [Abstract][Full Text] [Related]
11. Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers.
Jespers VA; Van Roey JM; Beets GI; Buvé AM
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):154-8. PubMed ID: 17106275
[TBL] [Abstract][Full Text] [Related]
12. Advances in microbicide vaginal rings.
Malcolm RK; Edwards KL; Kiser P; Romano J; Smith TJ
Antiviral Res; 2010 Dec; 88 Suppl 1():S30-9. PubMed ID: 21109066
[TBL] [Abstract][Full Text] [Related]
13. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women.
Nel A; Haazen W; Nuttall J; Romano J; Rosenberg Z; van Niekerk N
AIDS; 2014 Jun; 28(10):1479-87. PubMed ID: 24901365
[TBL] [Abstract][Full Text] [Related]
14. Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES.
McBride JW; Boyd P; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Malcolm RK
J Control Release; 2019 Mar; 298():1-11. PubMed ID: 30731150
[TBL] [Abstract][Full Text] [Related]
15. A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine.
Major I; Boyd P; Kilbourne-Brook M; Saxon G; Cohen J; Malcolm RK
Contraception; 2013 Jul; 88(1):58-66. PubMed ID: 23177261
[TBL] [Abstract][Full Text] [Related]
16. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1.
Gupta KM; Pearce SM; Poursaid AE; Aliyar HA; Tresco PA; Mitchnik MA; Kiser PF
J Pharm Sci; 2008 Oct; 97(10):4228-39. PubMed ID: 18338805
[TBL] [Abstract][Full Text] [Related]
17. Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial.
Nel A; Martins J; Bekker LG; Ramjee G; Masenga G; Rees H; van Niekerk N
PLoS One; 2018; 13(5):e0196904. PubMed ID: 29813074
[TBL] [Abstract][Full Text] [Related]
18. Impact of ring size and drug loading on the pharmacokinetics of a combination dapivirine-darunavir vaginal ring in cynomolgus macaques.
Murphy DJ; Desjardins D; Boyd P; Dereuddre-Bosquet N; Stimmer L; Caldwell A; Le Grand R; Kelly C; van Roey J; Malcolm RK
Int J Pharm; 2018 Oct; 550(1-2):300-308. PubMed ID: 30153490
[TBL] [Abstract][Full Text] [Related]
19. Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
Martinez J; Coplan P; Wainberg MA
Antiviral Res; 2006 Sep; 71(2-3):343-50. PubMed ID: 16787667
[TBL] [Abstract][Full Text] [Related]
20. Short-term antiviral activity of TMC278--a novel NNRTI--in treatment-naive HIV-1-infected subjects.
Goebel F; Yakovlev A; Pozniak AL; Vinogradova E; Boogaerts G; Hoetelmans R; de Béthune MP; Peeters M; Woodfall B
AIDS; 2006 Aug; 20(13):1721-6. PubMed ID: 16931936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
